Intuitive Biosciences
Middleton, US · Founded 2012 · Wisconsin corporation
Intuitive Bio develops immunoassays and diagnostic products and services, including non-human primate viral and TB tests and test processing, for research laboratories. The company offers assay development from proof of concept to fully-validated assays in a multiplex format supporting 1–100 markers per well.
BiotechHealthtechMedical Devices
Founders & leadership
SD
Shawn D GuseExecutive
JR
Jason R SmithNamed on SEC filing
CS
Craig SmithNamed on SEC filing
JR
Jason R. SmithNamed on SEC filing
Board
HN
Harald NordalBoard director
CE
Craig E SmithBoard director
Reported raises · per SEC filings
Form D private placements$3M disclosed across 3 rounds · 2014–2019
▶$1.2MraisedOct 2019 · 5 investors · BiotechnologyRule 506(b)
▶$1.2MraisedOct 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Craig SmithDirector
- Jason R SmithDirector
- Johan MichelsenDirector
- Shawn D GuseExecutive Officer, Director
- Jay SekelskyDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Sep 2019
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$1.3MraisedJun 2015 · 5 investors · BiotechnologyRule 506(b)
▶$1.3MraisedJun 2015 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Harald NordalDirector
- Craig E SmithDirector
- Jason R SmithDirector
- Shawn D GuseExecutive Officer, Director
- Offering amount
- $2.9M
- Amount sold
- $1.3M
- First sale
- May 2015
- Incorporated
- Corporation, Wisconsin, 2012
- Federal exemptions
- 06b
▶$486.9KraisedAug 2014 · 5 investors · BiotechnologyRule 506(b)
▶$486.9KraisedAug 2014 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Craig SmithDirector
- Jason R. SmithDirector
- Harald NordalExecutive Officer, Director
- Shawn D GuseExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $486.9K
- First sale
- Aug 2014
- Incorporated
- Corporation, Wisconsin, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapIQVIA31 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Precision BioSciences30 shared keywordsPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
Life Biosciences20 shared keywordsLongevity company with diversified therapies to extend healthy human lifespan
Twist Bioscience19 shared keywordsTwist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals. The platform enables faster and more affordable DNA synthesis at scale with customizable high-throughput capabilities.
Companies competing with Intuitive Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $306.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $299.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Intuitive Biosciences do?
- Intuitive Bio develops immunoassays and diagnostic products and services, including non-human primate viral and TB tests and test processing, for research laboratories. The company offers assay development from proof of concept to fully-validated assays in a multiplex format supporting 1–100 markers per well.
- How much funding has Intuitive Biosciences raised?
- Intuitive Biosciences has disclosed $3M raised across 3 rounds.
- Where is Intuitive Biosciences headquartered?
- Intuitive Biosciences is headquartered in Middleton, US.